Search Results 1081-1090 of 25312 for Pulmonary
... pulmonary vascular remodeling in patients with SSc. pulmonary related vascular structures. Participation eligibility. Participant eligibility includes age ...
Quit smoking, or don't start. Smoking is the leading cause of chronic obstructive pulmonary disease, also called COPD. If you have COPD, quitting can slow ...
Mayo Clinic has a long history of interventional pulmonary practice dating back to the 1950's, and current faculty members include past presidents and board ...
Cardiologist; Vascular Medicine Specialist. Rochester, MN. Areas of focus: Anticoagulant therapy, Aneurysm, Deep vein thrombosis, Pulmonary embolism, Abdominal ...
The purpose of this study is to evaluate the effectiveness of namilumab in subjects with chronic pulmonary sarcoidosis (CPS). Sarcoidosis is a multi-organ ...
Farah is a board-certified Pulmonary and Preventive Medicine physician, with special interests in airway diseases, occupational lung disease, and lung cancer ...
... Pulmonary Adenocarcinoma. Mod Pathol. 2026 Jan; 39 (1):100923 Epub 2025 Oct ... Pulmonary Resections for Clinical Stage IA Non-small Cell Lung Cancer.
Clinical Trials · A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF) · More about research at Mayo ...
Mayo Clinic pulmonary scientists in Pulmonary and Critical Care Medicine Research actively research lung diseases and conduct clinical trials. Researchers ...
... pulmonary sarcoidos, and to explore the utility of serum biomarkers in the evaluation of interventions to treat pulmonary sarcoidosis. Rilonacept in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.